JENNIFER BYRD: Open Payments
NPI 1679912190 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 31 payments from 7 companies in 2025. Trend: 2023 $482 · 2024 $392 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $426 |
| Abbott Laboratories | 4 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Averitas Pharma Inc. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Baxter Healthcare | 1 | $21 |
| BIOTRONIK NRO, Inc. | 1 | $19 |
Products named: BOTOX, ETERNA, RELISTOR, QUTENZA, PROCLAIM, AXIUM, QULIPTA, FLOSEAL.
Industry payments across AL — which companies pay providers there.
